Published by Iain Gilbert on 9th May 2019
(Sharecast News) - Anti-microbial technology company Byotrol expects to report an EBITDA loss from its last trading year as a result of delayed regulatory approval and higher costs in the US.
URL: http://www.digitallook.com/dl/news/story/29011889/...